Insider Transactions Reported by 24 Insiders of Tango Therapeutics, Inc.

Symbol
TNGX on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Tango Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Boxer Capital, LLC Other* $139,494,711 13 Oct 2023
Third Rock Ventures IV, L.P. 10%+ Owner $135,900,499 -$26,351,492 -16% 23 Oct 2025
BCTG Holdings, LLC 10%+ Owner $58,642,879 10 Aug 2021
EcoR1 Capital, LLC 10%+ Owner $31,010,920 06 Nov 2024
Barbara Weber Director, Executive Chair, Director $21,012,651 -$374,294 -1.8% 02 Feb 2026
Boxer Capital Management, LLC Other* $11,337,416 06 Nov 2024
Malte Peters President & CEO, Director $3,256,050 08 Jan 2026
Daniella Beckman Chief Financial Officer $2,376,896 -$126,531 -5.1% 02 Feb 2026
Adam Crystal President, R&D $1,689,330 -$1,224,274 -42% 05 Mar 2026
Third Rock Ventures VI, L.P. Director $1,629,392 11 Aug 2023
Alan Huang Chief Scientific Officer $1,406,264 01 Mar 2023
MVA Investors, LLC Other* $944,323 28 Jun 2024
Braslyn Ltd. 10%+ Owner $226,241 10 Aug 2021
Douglas Barry General Counsel $208,697 04 Feb 2025
Sung Lee Director $88,595 02 Jan 2026
Mace Rothenberg Director $42,750 05 Jun 2025
Reid M. Huber Director $41,957 06 Jun 2023
John B. Ketchum Director $23,868 05 Jun 2025
Alexis Borisy Director $19,950 05 Jun 2025
Lesley Ann Calhoun Director $14,250 05 Jun 2025
Davis Aaron I. Other* 03 Sep 2024
Aaron Weitzman Chief Medical Officer 01 Dec 2022
Marc Rudoltz Chief Medical Officer 01 Nov 2021
Kanishka Pothula Director 06 Nov 2023

Recent Insider Transactions by Companies or Individuals for Tango Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.